These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

345 related articles for article (PubMed ID: 24980564)

  • 21. Expanded access study of patients with advanced basal cell carcinoma treated with the Hedgehog pathway inhibitor, vismodegib.
    Chang AL; Solomon JA; Hainsworth JD; Goldberg L; McKenna E; Day BM; Chen DM; Weiss GJ
    J Am Acad Dermatol; 2014 Jan; 70(1):60-9. PubMed ID: 24189279
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Current landscape for treatment of advanced basal cell carcinoma.
    Foley P
    Australas J Dermatol; 2015 Mar; 56 Suppl 1():1-7. PubMed ID: 25715811
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A review of laser and photodynamic therapy for the treatment of nonmelanoma skin cancer.
    Marmur ES; Schmults CD; Goldberg DJ
    Dermatol Surg; 2004 Feb; 30(2 Pt 2):264-71. PubMed ID: 14871220
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Vismodegib: an inhibitor of the Hedgehog signaling pathway in the treatment of basal cell carcinoma.
    Proctor AE; Thompson LA; O'Bryant CL
    Ann Pharmacother; 2014 Jan; 48(1):99-106. PubMed ID: 24259609
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Conventional and combination topical photodynamic therapy for basal cell carcinoma: systematic review and meta-analysis.
    Collier NJ; Haylett AK; Wong TH; Morton CA; Ibbotson SH; McKenna KE; Mallipeddi R; Moseley H; Seukeran D; Ward KA; Mohd Mustapa MF; Exton LS; Green AC; Rhodes LE
    Br J Dermatol; 2018 Dec; 179(6):1277-1296. PubMed ID: 29889302
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Not Available].
    Basset-Seguin N
    Ann Dermatol Venereol; 2018 Nov; 145 Suppl 5():VS36-VS41. PubMed ID: 30477683
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Systemic treatments for basal cell carcinoma (BCC): the advent of dermato-oncology in BCC.
    Ali FR; Lear JT
    Br J Dermatol; 2013 Jul; 169(1):53-7. PubMed ID: 23488543
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Known and new facts on basal cell carcinoma.
    Seidl-Philipp M; Frischhut N; Höllweger N; Schmuth M; Nguyen VA
    J Dtsch Dermatol Ges; 2021 Jul; 19(7):1021-1041. PubMed ID: 34288482
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Basal cell carcinoma: Contemporary approaches to diagnosis, treatment, and prevention.
    Cameron MC; Lee E; Hibler BP; Giordano CN; Barker CA; Mori S; Cordova M; Nehal KS; Rossi AM
    J Am Acad Dermatol; 2019 Feb; 80(2):321-339. PubMed ID: 29782901
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Vismodegib as Eye-Sparing Neoadjuvant Treatment for Locally Advanced Periocular Basal Cell Carcinoma.
    Angnardo L; Humeda Y; Alexandraki I; Wolfe CM; Cognetta AB
    J Drugs Dermatol; 2021 May; 20(5):552-554. PubMed ID: 33938701
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Vismodegib for the treatment of basal cell skin cancer.
    Poggi L; Kolesar JM
    Am J Health Syst Pharm; 2013 Jun; 70(12):1033-8. PubMed ID: 23719880
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Concurrent Vismodegib and Radiotherapy for Recurrent, Advanced Basal Cell Carcinoma.
    Pollom EL; Bui TT; Chang AL; Colevas AD; Hara WY
    JAMA Dermatol; 2015 Sep; 151(9):998-1001. PubMed ID: 25874733
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Combination vismodegib and photodynamic therapy for multiple basal cell carcinomas.
    Rizzo JM; Segal RJ; Zeitouni NC
    Photodiagnosis Photodyn Ther; 2018 Mar; 21():58-62. PubMed ID: 29102653
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A Review on Imiquimod Therapy and Discussion on Optimal Management of Basal Cell Carcinomas.
    Kamath P; Darwin E; Arora H; Nouri K
    Clin Drug Investig; 2018 Oct; 38(10):883-899. PubMed ID: 30128748
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Vismodegib and the hedgehog pathway: a new treatment for basal cell carcinoma.
    Cirrone F; Harris CS
    Clin Ther; 2012 Oct; 34(10):2039-50. PubMed ID: 23036338
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Vismodegib: the first drug approved for advanced and metastatic basal cell carcinoma.
    Dubey AK; Dubey S; Handu SS; Qazi MA
    J Postgrad Med; 2013; 59(1):48-50. PubMed ID: 23525058
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Current diagnosis and treatment of basal cell carcinoma.
    Alter M; Hillen U; Leiter U; Sachse M; Gutzmer R
    J Dtsch Dermatol Ges; 2015 Sep; 13(9):863-74; quiz 875. PubMed ID: 26882375
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Diagnosis and treatment of basal cell carcinoma : A question of the risk of recurrence].
    Lang BM; Grabbe S
    Hautarzt; 2020 Aug; 71(8):580-587. PubMed ID: 32533202
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Japanese Dermatological Association guidelines: Outlines of Japanese clinical guidelines for basal cell carcinoma 2021.
    Hoashi T; Ishikawa M; Uehara J; Oashi K; Maeda S; Kato J; Saruta H; Shichinohe R; Ohashi R; Nakamura Y; Koga H; Sugaya M;
    J Dermatol; 2024 Apr; 51(4):e90-e105. PubMed ID: 38264942
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Vismodegib in the treatment of basal cell carcinoma: indications for clinical practice.
    Calzavara Pinton P; Licitra L; Peris K; Santoro A; Ascierto PA
    Future Oncol; 2015; 11(9):1429-35. PubMed ID: 25952787
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.